[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-354098-105":59,"doc-detail-354098-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","spliceosomal-mutation-drives-melanoma-tumorigenesis-via-lineage-specific-ras-activation","Spliceosomal mutation drives melanoma tumorigenesis via lineage-specific RAS activation","","Splicing factor mutations recur across human cancers and trigger broad RNA splicing dysregulation. SF3B1 is frequently mutated, yet hotspot variants show lineage specificity, with SF3B1R625 in melanoma and SF3B1K700E in hematologic malignancies, leaving the mechanism unclear. SF3B1R625H produces stronger activation of alternative 3′ splice sites through polyadenine-enriched sequences around cryptic branch point sites, creating splice bias. This causes preferential missplicing of NF1, enabling RAS hyperactivation and accelerating melanoma progression in mouse models. ",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/spliceosomal-mutation-drives-melanoma-tumorigenesis-via-lineage-specific-ras-activation/354098/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/spliceosomal-mutation-drives-melanoma-tumorigenesis-via-lineage-specific-ras-activation/354098.png","ImageObject",300,407,{"name":92,"@type":93},"Melati","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-29","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",11,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"What makes SF3B1 mutations important in cancer?","Question",{"text":113,"@type":114},"Mutations in splicing factors, especially SF3B1, drive widespread RNA splicing dysregulation that contributes to tumor initiation and progression.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"How do SF3B1 hotspot mutations differ by cancer lineage?",{"text":118,"@type":114},"SF3B1R625 mutations are predominantly found in melanoma, whereas SF3B1K700E is more associated with hematologic malignancies.",{"name":120,"@type":111,"acceptedAnswer":121},"What mechanism links SF3B1R625H to melanoma progression?",{"text":122,"@type":114},"SF3B1R625H enhances activation of alternative 3′ splice sites, causing preferential missplicing of NF1, which releases NF1-mediated suppression and leads to RAS hyperactivation and faster melanoma progression in mouse models.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},354098,1790768863,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":140,"language":141,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":67,"update_tm":145,"read_time":36,"preview_page_count":19,"preview_urls":146},962085570644,"https://ap-avatar.wpscdn.com/davatar_994ba38a5ba835b3df7d355c54d3ed8d","CANCER  \nSpliceosomal mutation drives melanoma tumorigenesis via lineage-specific RAS activation  \nRuixinJiang1,2†, Peiqi Xing3,4*†, Jindou Xie3,4,5, Gang Bai2, Yuzhu Zhang2, Pengcong Hou2, Hao Luo2, Yanni Ma2, Ruixin Liu2, Yang Zheng6, Xiangyu Chen7, Bin Jiang1, Jing Huang2, Yanjie Zhang1,2, A. Hunter Shain8,9, Ming Lei2,10, Robert L. Judson-Torres11,12,13, Jing Ye14, Zhaoqi Liu3,4,5*, Hanlin Zeng1,2*  \nMutations in splicing factors are recurrent across human cancers and drive widespread RNA splicing dysregulation. Among these, SF3B1 is the most frequently mutated, yet its hotspot mutations exhibit lineage specificity, with SF3B1R625 mutations predominantly found in melanoma and SF3B1K700E in hematologic malignancies. However, the mechanistic basis for this cancer-type specificity remains unclear. Here, we demonstrate that SF3B1R625Hinduces greater activation of alternative 3′ splice site than SF3B1K700E. Mechanistically, the polyadenine-enriched sequence surrounding cryptic branch point sites confers SF3B1R625H selective advantage in aberrant splicing. This splicing bias leads to preferential missplicing of NF1, a RAS inhibitor, resulting in RAS hyperactivation and accelerated melanoma progression in mouse models. This study redefines the oncogenic paradigm of SF3B1 mutations by demonstrating that distinct hotspot mutations exploit lineage-specific splicing vulnerabilities to drive tumorigenesis and establishes RAS activation as key mechanism underlying SF3B1R625H-driven melanoma, positioning RAS pathway as tractable therapeutic target in SF3B1-mutant melanoma.  \ncopyright © 2026 the Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. no claim to original U.S.  \nGovernment Works. distributed under a creative commons Attribution license 4.0 (cc BY) .  \nINTRODUCTION  \nIn eukaryotic cells, gene expression requires processing pre-mRNA into mature mRNA through the splicing of introns and joining of exons within the nucleus (1) . Cancer cells can “hijack” this splicing machinery to induce specific splicing abnormalities that drive tumor initiation and progression (2, 3). Comprehensive genomic analyses of cancer have identified recurrent mutations of splicing factors in human cancers, providing the most direct evidence of dysregulated splicing functions in cancer (4) . Mutations in the core RNA splicing factor SF3B1 are the most common across cancer types and occur as “hotspot” heterozygous point mutations (5). Analysis of the effects of SF3B1 hotspot mutations on RNA splicing has consistently identified that these mutations use aberrant branch point nucleotides, manifesting in increased use of cryptic 3′ splice site (3′ss) and resulting in alternative splicing events (6, 7). The resulting aberrantly spliced transcripts frequently lead to nonsense-mediated decay  \n1department of Oncology, Shanghai ninth People’s hospital, Shanghai Jiao tong University School of Medicine, Shanghai, china. 2Shanghai institute of Precision Medicine, Shanghai ninth People’s hospital, Shanghai Jiao tong University School of Medicine, Shanghai, china. 3department of computational Biology, china national center for Bioinformation, Beijing, china. 4Beijing institute of Genomics, chinese Academy of Sciences, Beijing, china. 5University of chinese Academy of Sciences, Beijing, china. 6department of Oral and Maxillofacial-head neck Oncology, Shanghai ninth People’s hospital, Shanghai Jiao tong University School of Medicine, college of Stomatology, Shanghai Jiao tong University, Shanghai, china. 7department of Plastic and Reconstructive Surgery, Shanghai ninth People’s hospital, Shanghai Jiao tong University School of Medicine, Shanghai, china. 8department of dermatology, University of california, San Francisco, San Francisco, cA, USA. 9helen diller Family comprehensive cancer center, University of california, San Francisco, San Francisco, cA, USA. 10State Key laboratory of Oncogenes and Related Genes, Shangha","cbCaisrs2TQSvq5G","https://ap.wps.com/l/cbCaisrs2TQSvq5G","pdf",3771297,16,"English","# Introduction\n## Splicing dysregulation in cancer\n## SF3B1 hotspot mutations and lineage specificity\n## Mechanistic clues and current research context","[{\"question\":\"What makes SF3B1 mutations important in cancer?\",\"answer\":\"Mutations in splicing factors, especially SF3B1, drive widespread RNA splicing dysregulation that contributes to tumor initiation and progression.\"},{\"question\":\"How do SF3B1 hotspot mutations differ by cancer lineage?\",\"answer\":\"SF3B1R625 mutations are predominantly found in melanoma, whereas SF3B1K700E is more associated with hematologic malignancies.\"},{\"question\":\"What mechanism links SF3B1R625H to melanoma progression?\",\"answer\":\"SF3B1R625H enhances activation of alternative 3′ splice sites, causing preferential missplicing of NF1, which releases NF1-mediated suppression and leads to RAS hyperactivation and faster melanoma progression in mouse models.\"}]","Spliceosomal mutation drives melanoma tumorigenesis via lineage-specific RAS activation | PDF",1790108918,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/6c69461d7804785a5b5b55d6161b190e.webp",983,1250,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/0a46ddbda460073e405eb23879e140f1.webp",982,1249,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a7a2cd22daee42c4b7447f14b0a3439d.webp",981,1248,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f2c5e860ccfa6c869b076d795c3623a2.webp",980,1247]